The Economic and Humanistic Burden of Pediatric-Onset Multiple Sclerosis
# Background Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system. Pediatric-onset MS (POMS), defined as onset of MS before 18 years of age, is estimated to account for 2% to 5% of the MS population worldwide. # Objectives To conduct a literature review...
Saved in:
Main Authors: | Nupur Greene, Lita Araujo, Cynthia Campos, Hannah Dalglish, Sarah Gibbs, Irina Yermilov |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2022-10-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/001c.37992 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A study of patients with aggressive multiple sclerosis at disease onset
by: Kaunzner U, et al.
Published: (2016-08-01) -
Clinical and immunological features of the pediatric multiple sclerosis
by: V. M. Lebedev, et al.
Published: (2025-06-01) -
Therapeutic options and outcomes in pediatric-onset multiple sclerosis with a focus on fingolimod—Eastern European tertiary center experience and literature review
by: Alice Denisa Dică, et al.
Published: (2025-06-01) -
Temporal trends in the burden of multiple sclerosis in the UK over the past three decades
by: Zaid Abdulelah, et al.
Published: (2025-07-01) -
Features of Tuberous Sclerosis Onset: Clinical Case
by: Еlena S. Zastelo, et al.
Published: (2025-05-01)